|
Volumn 195, Issue 6, 2002, Pages
|
Harnessing a neural-immune circuit to control inflammation and shock
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BACTERIUM LIPOPOLYSACCHARIDE;
CYTOKINE;
SEMAPIMOD;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL MODEL;
BRAIN ISCHEMIA;
CENTRAL NERVOUS SYSTEM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
ENDOTOXEMIA;
HUMAN;
HYPOTENSION;
ILLNESS BEHAVIOR;
IMMUNOREGULATION;
INFLAMMATION;
NEUROIMMUNOLOGY;
NONHUMAN;
NOTE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RAT;
SHOCK;
VAGUS NERVE;
|
EID: 0037128643
PISSN: 00221007
EISSN: None
Source Type: Journal
DOI: 10.1084/jem.20020602 Document Type: Note |
Times cited : (57)
|
References (25)
|